18 November 2026
14:00–15:00 CET
Webinar

Trusting MRgRT for pancreatic cancer

This webinar will present the evolution of ablative dose radiation at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center over the past 20 years.

Learning objectives

Understand how curative ablative hypofractionated treatment has evolved to MRgRT to address the limitation of the sensitivity of the surrounding mobile GI tract.
Review the importance of treating regional disease, which is present 80% of the time, for cure.
Examine why full doses and regional volumes must be used for treatment to become a standard competitive with surgery.
Explore tools being developed to enhance the ability and efficiency of MRgRT delivered with Elekta Unity, including 3-D MLC tracking (MRSigma) and interfraction GI dose accumulation.

In partnership with

The International Stereotactic Radiosurgery Society (ISRS) is a global community of experts who share a passion for Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT) and other focal therapies.

Meet the speakers

Christopher Crane, MD

Speaker. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY

About the event

Duration: 60 minutes

Past Events

13 October 2026

Ultrafractionated stereotactic adaptive radiotherapy (PULSAR) SRS and CNS active drugs

Zabi Wardak MD, Victor Ho-Fun Lee, MD

Stereotactic radiotherapy has long been used for the treatment of intracranial brain tumors, with treatment decisions driven primarily by size. However, modern drugs capable of penetrating the blood-brain barrier (BBB) have introduced a synergistic effect with stereotactic radiosurgery (SRS).

Recording coming soon

26 September 2026

The Adaptive Exchange at ASTRO

Arjun Sahgal, MD, Dr. Marsha Reyngold, Arnold Pompos, PhD, Dr. Sarah Dooley, Dr. Anthony Paravati, Dr. Chirag Shah, Dr. Matthias Lampe

An invite-only panel discussion focused on implementing and sustaining adaptive radiotherapy programs from clinical, operational, and financial perspectives.

Watch the recording

24 September 2026

UICC World Cancer Congress, Hong Kong

A global panel discussion exploring the practical strategies to expand access to high-quality radiotherapy.

5 August 2026

Making adaptive radiotherapy routine in emerging markets

Dr. John Christodouleas, Dr. Vadhiraja B.M., Dr. Kausik Bhattacharya, Dr. Vikram Maiya M, Dr. T. Surendra Reddy, Dr. Ramesh S. Bilimagga

Five clinicians, one question. What would it take to make adaptive radiotherapy standard practice where the need is greatest, and the resources are tightest?